会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Nonantigenic keratinous protein material
    • 非抗原性角质蛋白材料
    • US5358935A
    • 1994-10-25
    • US978768
    • 1992-11-19
    • Robert A. SmithCheryl R. BlanchardJames Lankford, Jr.
    • Robert A. SmithCheryl R. BlanchardJames Lankford, Jr.
    • A61K38/00A61L27/22A61L27/26A61L27/34A61L27/44A61L27/50C07K14/47A61F2/02A61K37/12C07K3/02
    • C07K14/4741A61L27/227A61L27/26A61L27/34A61L27/44A61L27/50A61K38/00Y10S514/937Y10S530/842Y10S623/901
    • The present invention is a new nonantigenic keratinous protein material that may be used as a number of purposes, including correction of soft tissue deficiencies and the creation of biomedical implants and implant coatings. The present invention also includes processes for using the nonantigenic keratinous protein material for soft tissue augmentation, creating implants, and the coating of biocompatible implants. The nonantigenic keratinous protein material can be formed by obtaining nonantigenic keratinous protein and processing it to a powder form. If hair from the recipient or a compatible doner is used, it is bleached and rinsed, then dried and chopped into about 0.25 inch pieces. The keratinous protein is then homogenized in a solvent to a particular size generally in the range of about 0.1 to about 500 .mu.m. The particles are then ultrasonicated in a solvent. Afterwards, the solvent is evaporated, and the powdered protein is sterilized and suspended in a sterile bioinert solvent to create a protein colloid at a solids concentrations suitable for injection.
    • 本发明是一种新的非抗原性角质蛋白材料,其可用作许多目的,包括矫正软组织缺陷以及生物医学植入物和植入物涂层的产生。 本发明还包括使用非抗原角质蛋白材料用于软组织增加,产生植入物和生物相容性植入物的包衣的方法。 非抗原角化蛋白质材料可以通过获得非抗原角化蛋白质并将其加工成粉末形式来形成。 如果使用来自接收者的头发或使用相容的发丝器,则将其漂白并漂洗,然后干燥并切碎成约0.25英寸的片。 然后将角质蛋白质在溶剂中均化至一般在约0.1至约500μm范围内的特定尺寸。 然后将颗粒在溶剂中超声波处理。 然后蒸发溶剂,将粉状蛋白质灭菌并悬浮于无菌生物惰性溶剂中以产生适于注射的固体浓度的蛋白质胶体。